| 1 |
Murgia N, Gambelunghe A. Occupational COPD-the most under-recognized occupational lung disease？[J]. Respirology, 2022, 27(6): 399-410.
|
| 2 |
Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment[J]. Lancet Respir Med, 2022, 10(5): 497-511.
|
| 3 |
He G, Dong T, Yang Z, et al. Point-of-care COPD diagnostics: biomarkers, sampling, paper-based analytical devices, and perspectives[J]. Analyst, 2022, 147(7): 1273-1293.
|
| 4 |
Kahnert K, Jörres RA, Behr J, et al. The diagnosis and treatment of COPD and its comorbidities[J]. Dtsch Arztebl Int, 2023, 120(25): 434-444.
|
| 5 |
Lineros R, Fernández-Delgado L, Vega-Rioja A, et al.Associated factors of pneumonia in individuals with chronic obstructive pulmonary disease (COPD) apart from the use of inhaled corticosteroids[J]. Biomedicines, 2023, 11(5): 1243.
|
| 6 |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组，中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志，2021, 44(3): 170-205.
|
| 7 |
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J]. 中华结核和呼吸杂志，2016, 39(4): 253-279.
|
| 8 |
Volpato E, Farver-Vestergaard I, Brighton LJ, et al. Nonpharmacological management of psychological distress in people with COPD[J]. Eur Respir Rev, 2023, 32(167): 220170.
|
| 9 |
Burke H, Wilkinson TMA. Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care[J]. Eur Respir Rev, 2021, 30(160): 210041.
|
| 10 |
Nava VE, Khosla R, Shin S, et al. Enhanced carbonic anhydrase expression with calcification and fibrosis in bronchial cartilage during COPD[J]. Acta Histochem, 2022, 124(1): 151834.
|
| 11 |
Upadhyay P, Wu CW, Pham A, et al. Animal models and mechanisms of tobacco smoke-induced chronic obstructive pulmonary disease (COPD)[J]. J Toxicol Environ Health B Crit Rev, 2023, 26(5): 275-305.
|
| 12 |
Yang HJ, Zhang Z, Wang ZM. The relationship between oral microbiota and chronic obstructive pulmonary disease[J]. Sichuan Da Xue Xue Bao Yi Xue Ban, 2023, 54(1): 54-60.
|
| 13 |
De Nuccio F, Piscitelli P, Toraldo DM. Gut-lung microbiota interactions in chronic obstructive pulmonary disease (COPD): Potential mechanisms driving progression to COPD and epidemiological data[J]. Lung, 2022, 200(6): 773-781.
|
| 14 |
Marin-Corral J, Pascual-Guardia S, Amati F, et al. Aspiration risk factors, microbiology, and empiric antibiotics for patients hospitalized with community-acquired pneumonia[J]. Chest, 2021, 159(1): 58-72.
|
| 15 |
Agustí A, Melén E, DeMeo DL, et al. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan[J]. Lancet Respir Med, 2022, 10(5): 512-524.
|
| 16 |
Kitsios GD, Nguyen VD, Sayed K, et al. The upper and lower respiratory tract microbiome in severe aspiration pneumonia[J]. Science, 2023, 26(6): 106832.
|
| 17 |
Babayev R, Taylor S, Franklin EV. Case of nocturnal emesis, weight loss, and aspiration pneumonia[J]. Clin Pediatr (Phila), 2023, 29: 99228231171065.
|
| 18 |
Hashiguchi MH, Chubachi S, Yamasawa W, et al. Interaction of BMI and respiratory status in obstructive sleep apnea, a cross-sectional COPD study[J]. NPJ Prim Care Respir Med, 2023, 33(1): 30.
|
| 19 |
Won JH, Byun SJ, Oh BM, et al. Risk and mortality of aspiration pneumonia in Parkinson's disease: a nationwide database study[J]. Sci Rep, 2021, 11(1): 6597.
|
| 20 |
Khijmatgar S, Belur G, Venkataram R, et al. Oral candidal load and oral health status in chronic obstructive pulmonary disease (COPD) patients: A case-cohort study[J]. Biomed Res Int, 2021, 2021: 5548746.
|
| 21 |
Pei Y, Wei Y, Peng B, et al. Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveal the cellular and genetic profiles in COPD[J]. Respir Res, 2022, 23(1): 260.
|
| 22 |
Bouquet J, Tabor DE, Silver JS, et al. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort[J]. Respir Res, 2020, 21(1): 77.
|
| 23 |
Singanayagam A, Footitt J, Marczynski M, et al. Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease[J]. J Clin Invest, 2022, 132(8): e120901.
|
| 24 |
Sim YS, Lee JH, Lee EG, et al. COPD exacerbation-related pathogens and previous COPD treatment[J]. J Clin Med, 2022, 12(1): 111.
|
| 25 |
Qin SG, Xiao W, Zhou CM, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics[J]. Signal Transduct Target Ther, 2022, 7: 199.
|
| 26 |
Begley LA, Opron K, Bian G, et al. Effects of fluticasone propionate on klebsiella pneumoniae and gram-negative bacteria associated with chronic airway disease[J]. Sphere, 2022, 7(6): e0037722.
|
| 27 |
Ibrahim ME. Risk factors in acquiring multidrug-resistant Klebsiella pneumoniae infections in a hospital setting in Saudi Arabia[J]. Sci Rep, 2023, 13(1): 11626.
|
| 28 |
Kaleem Ullah M, Malamardi S, Siddaiah JB, et al.Trends in the bacterial prevalence and antibiotic resistance patterns in the acute exacerbation of chronic obstructive pulmonary disease in hospitalized patients in south India[J]. Antibiotics (Basel), 2022, 11(11): 1577.
|
| 29 |
Hong J, Son M, Sin J, et al. Nanoparticles of Lactiplantibacillus plantarum K8 reduce staphylococcus aureus respiratory infection and tumor necrosis factor Alpha-and interferon Gamma-induced lung inflammation[J]. Nutrients, 2023, 15(22): 4728.
|
| 30 |
Karakioulaki M, Berkemeier CM, Heijnen I, et al. Staphylococcus aureus enterotoxin A- and B-specific IgE in chronic obstructive pulmonary disease[J]. Respir Res, 2023, 24(1): 225.
|